Relationship Graph Explorer
Follow the connections
Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.
🌿
Herb
6,826
→
⚗️
Ingredient
44,598
→
🧬
Gene Target
15,695
→
🏥
Disease
30,467
→
🧪
Evidence
23,295
trials · metas · refs
Plus 6,743 TCM formulas connecting herbs together
⚗️ Ingredient
Thymidine
3
Clinical Trials
0
Meta-Analyses
1
PubMed References
Top Conditions Studied with Thymidine
📋 Sample Trials
NCT00004658
Phase II Study of Ribose, Uridine, and Thymidine for a Complex Syndrome Involving Excessive 5'-Nucleotidase Activity
Completed · Phase 2
NCT03639701
Treatment of TK2 Deficiency With Thymidine and Deoxycytidine
Active_Not_Recruiting · Phase 1|Phase 2
NCT04802707
Deoxynucleosides Pyrimidines as Treatment for Mitochondrial Depletion Syndrome
Recruiting · Phase 2
📊 Sample Meta-Analyses
None linked yet.
📚 Sample References
PMID 35301470
Induction of functional neutrophils from mouse fibroblasts by thymidine through enhancement of Tet3 activity
Cell Mol Immunol · 2022
⚗️ All Ingredient data fields for Thymidine
⚗️ Identity
Name
Thymidine
Aliases / Synonyms
50-89-5; deoxythymidine; 2'-Deoxythymidine; Thymidin; 5-Methyldeoxyuridine; Beta-Thymidine; DThyd; 5-Methyl-2'-deoxyuridine; 5-Methyldeoxyurindine
🧪 Chemistry
Molecular Weight
242.2310
LogP
-1.5143
Drug-likeness
0.584
H-Bond Acceptors
6
H-Bond Donors
3
Rotatable Bonds
2
🔬 Structures
Canonical SMILES
CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)O
Isomeric SMILES
CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)O
InChIKey
IQFYYKKMVGJFEH-XLPZGREQSA-N
InChI
InChI=1S/C10H14N2O5/c1-5-3-12(10(16)11-9(5)15)8-2-6(14)7(4-13)17-8/h3,6-8,13-14H,2,4H2,1H3,(H,11,15,16)/t6-,7+,8+/m0/s1
🔗 External References
🔍 Raw view — every non-empty column on this row (31 fields)
name
Thymidine
common names
50-89-5; deoxythymidine; 2'-Deoxythymidine; Thymidin; 5-Methyldeoxyuridine; Beta-Thymidine; DThyd; 5-Methyl-2'-deoxyuridine; 5-Methyldeoxyurindine
herb ingredient id
HBIN046383
canonical smiles
CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)O
isomeric smiles
CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)O
inchi
InChI=1S/C10H14N2O5/c1-5-3-12(10(16)11-9(5)15)8-2-6(14)7(4-13)17-8/h3,6-8,13-14H,2,4H2,1H3,(H,11,15,16)/t6-,7+,8+/m0/s1
inchikey
IQFYYKKMVGJFEH-XLPZGREQSA-N
mol wt
242.2310
num h acceptors
6
num h donors
3
mol logp
-1.5143
num rotatable bonds
2
drug likeness
0.584
symmap mol id
17939
tcmid ingredient id
21343
tcm id ingredient id
24047
pubchem cid
5789
drugbank id
DB04485
npass id
NPC71339
📋 Clinical Trials
3 · subject of clinical studyNCT00004658 Phase II Study of Ribose, Uridine, and Thymidine for a Complex Syndrome Involvin
→ 5'-Nucleotidase Syndrome
NCT03639701 Treatment of TK2 Deficiency With Thymidine and Deoxycytidine
→ Mitochondrial DNA Depletion Syndrome 2 Myopathic T
NCT04802707 Deoxynucleosides Pyrimidines as Treatment for Mitochondrial Depletion Syndrome
→ Mitochondrial Diseases|Mitochondrial Encephalomyop
📚 PubMed References
1 · cited researchPMID 35301470 Induction of functional neutrophils from mouse fibroblasts by thymidine through
Cell Mol Immunol
How relationships are computed
- Clinical Trials / Meta-Analyses / References: direct foreign-key link via
subject_entity_id(Phase 2d wireup) - Formula ↔ Herbs: text bridge via
formulas.herbs_in_pinyinmatchingherbs.pinyin_name - Herb ↔ Ingredient:
ACTIVE — direct link via
herb_ingredients - Ingredient ↔ Target:
ACTIVE — direct link via
ingredient_targets - Target ↔ Disease:
ACTIVE — direct link via
target_health_topics - Herb → Target → Disease (full chemical spine): ACTIVE — joins all three link tables